MyFinsight
Home
Blog
About
Accounts receivable (net
of allowance for...
$1,492M
(0.54%↑ Y/Y)
Inventories (excludes
inventories of 273 in 2026 and...
$1,351M
(-7.08%↓ Y/Y)
Other current assets
$1,136M
(5.09%↑ Y/Y)
Cash and cash
equivalents
$1,132M
(88.98%↑ Y/Y)
Total current assets
$5,111M
(10.68%↑ Y/Y)
Goodwill
$4,153M
(-11.26%↓ Y/Y)
Other assets
$1,521M
(-3.37%↓ Y/Y)
Property, plant and
equipment, net
$1,281M
(1.18%↑ Y/Y)
Intangibles, net
$1,112M
(-18.36%↓ Y/Y)
Total assets
$13,178M
(-2.39%↓ Y/Y)
Total liabilities and
stockholders equity
$13,178M
(-2.39%↓ Y/Y)
Total liabilities
$12,172M
(-4.66%↓ Y/Y)
Total stockholders
equity
$1,006M
(37.24%↑ Y/Y)
Accumulated other
comprehensive loss
-$548M
(4.20%↑ Y/Y)
Long-term debt
$8,479M
(-3.44%↓ Y/Y)
Total current
liabilities
$2,616M
(-6.44%↓ Y/Y)
Other noncurrent
liabilities
$1,026M
(-8.47%↓ Y/Y)
Deferred income taxes
$51M
(-26.09%↓ Y/Y)
Retained earnings
$1,352M
(16.25%↑ Y/Y)
Additional paid-in capital
$199M
(43.17%↑ Y/Y)
Common stock, 0.01 par
value authorized -...
$3M
(0.00%↑ Y/Y)
Accrued and other
current liabilities
$1,407M
(-0.92%↓ Y/Y)
Trade accounts
payable
$1,051M
(-1.50%↓ Y/Y)
Income taxes payable
$84M
(-56.70%↓ Y/Y)
Current portion of
long-term debt and...
$74M
(164.35%↑ Y/Y)
Back
Back
Balance Sheet
organon-logo-svg
source: myfinsight.com
Organon & Co. (OGN)
organon-logo-svg
Organon & Co. (OGN)